Status:
RECRUITING
Optimizing the Care Pathway of Febrile Children Via Capillary C-reactive Protein Assay in Primary Care
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Fever
Eligibility:
All Genders
3-15 years
Phase:
NA
Brief Summary
Fever is the leading reason for outpatient consultations among children aged 2 to 9 years. The main concern in fever is severe bacterial infection, particularly for younger children. History and clini...
Eligibility Criteria
Inclusion
- The patient must be a member or beneficiary of a health insurance plan
- Children consulting primary health institutes with fever (temperature ≥ 38°C) requiring CRP testing:
- Fever \> 12h in infants aged 3 to 6 months
- Fever ≥ 5 days in children over 6 months of age
- Fever \>12h regardless of age, and at the time of consultation, the doctor is concerned about the child's general condition, the tolerance of the fever, or doubts about a bacterial focus (e.g. suspicion of pneumopathy, appendicitis, etc.).
- No severity criteria necessitating immediate hospitalization
- No bacterial infection whose diagnosis is exclusively clinical or identified by other means (e.g. purulent AOM, bacterial angina identified by RDT, etc.).
- Child whose parents and child have been informed about the study, and at least one parent has given consent for their child's participation in the study.
- Enrolment of the child according to their capacity of discernment (for children aged 12 and over, enrolment is essential).
- Child affiliated to or benefiting from a health insurance scheme
Exclusion
- The subject is participating in a category 1 interventional study, or a study with drug or medical device
- Premature infants under one year of age
- Immunosuppression
- Sunstroke
- Chronic infection
- Malignant pathology
- Autoimmune pathology
- Sickle cell disease
- Child with a central catheter
Key Trial Info
Start Date :
September 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
420 Patients enrolled
Trial Details
Trial ID
NCT06910631
Start Date
September 15 2025
End Date
March 1 2026
Last Update
November 19 2025
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
MSP OLEA
Bezouce, France
2
MSP Espace Santé Servian
Béziers, France
3
MSPU Avicenne
Cabestany, France
4
MSP de Calvisson
Calvisson, France